Trial Profile

A Trial Investigating the Pharmacodynamic Response of NN5401 in Subjects With Type 2 Diabetes.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 29 Nov 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin degludec/insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart
Indications Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

25 Nov 2010 Status changed from active, no longer recruiting to completed.
10 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
25 Aug 2010 Planned end date changed from 1 Oct 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com